Alcresta Therapeutics announces MGH enrols first patient in clinical trial evaluating use of RELiZORB in pancreatitis patients | On account of International Labour Day, Pharmabiz site will not be updated on May 1, 2025

Join Pharma | Login

	Editorial


	An Ill-informed Policy
	Wednesday, April 30, 2025
	In a controversial decision which has literally opened a Pandora's box, the Gujarat government has recently introduced a new differential pricing policy, which was later withdrawn, for the Drug-Eluting Stents (DES)
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Alcresta Therapeutics announces MGH enrols first patient in clinical trial evaluating use of RELiZORB in pancreatitis patients
17:45 [IST]	Strides strengthens anti-inflammatory portfolio with US FDA approval for celecoxib capsules 100 mg, 200 mg, & 400 mg
17:15 [IST]	Intuitive and HSSC come together to strengthen India’s healthcare workforce
17:00 [IST]	Axtria introduces LUCCID to transform clinical data management with GenAI
16:15 [IST]	Signify & SELCO Foundation team-up to solarize 10 24x7 primary health centres in Karnataka under the ‘Swasthya Kiran’ CSR initiative
16:00 [IST]	UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM

more news >>

TOP NEWS


08:00 [IST]	Panel asks Ministry to ensure effective implementation of central sector scheme on medicinal plants
08:00 [IST]	FOPE urges DCGI to review the list of 35 unapproved FDCs for manufacture and marketing
08:00 [IST]	NAB-CCM to host webinar on “Tariff vs Temperature: Economic Policies Challenging the Cold Chain Industry"
08:00 [IST]	TN CDA panel assures to create job avenues for Pharm D graduates
08:00 [IST]	Centre notifies new export norms for doxycycline 100 mg dispersible tablets
08:00 [IST]	Health ministry notifies rules on compounding of offences

more news >>

YESTERDAY'S NEWS


18:00 [IST]	LIfT BioSciences enters partnership with University of Galway for clinical trial in Ireland
17:45 [IST]	Apollo Cancer Centres launches ‘ColFit’, colorectal cancer screening programme amidst rising cases
17:30 [IST]	C-CAMP AMR Challenge 2024-25, in collaboration with GAMRIF, announces 9 winners to address AMR
17:15 [IST]	Encephalitis International notes climate change leading to more vaccine-preventable diseases
16:50 [IST]	Reckitt unveils first-of-its-kind art installation in Bhavnagar to raise awareness on vector-borne diseases
14:15 [IST]	Hon’ble Governor of Maharashtra, Shri C P Radhakrishnan, inaugurates newly revamped Aditya Jyot Eye Hospital in Mumbai

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Syngene’s revenue from operations crossed Rs. 1,000 crore mark in Q4, PAT dips by 3%, full year earnings up 4% to Rs. 3,642 crore Methotrexate 2.5 Mg Tab/cap Fluvoxamine 100mg Tab Vitamin D3 Inj -600000 Iu-1 Ml. Tab Tianeptine 12.5 Mg

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers